Outlook Therapeutics (OTLK) Interest Coverage Ratio Growth (1y) (2016 - 2021)
Outlook Therapeutics (OTLK) Interest Coverage Ratio Growth (1y) (2016 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
67.94% |
| 10 |
Outlook Therapeutics |
51.13 Mn |
43.39 Mn |
-21,888.00 |
- |
| Date | Value |
|---|
| Mar 31, 2021 |
-418.93% |
| Dec 31, 2020 |
-549.08% |
| Sep 30, 2020 |
-771.37% |
| Jun 30, 2020 |
-413.23% |
| Mar 31, 2020 |
-32.88% |
| Dec 31, 2019 |
-49.63% |
| Sep 30, 2019 |
-483.75% |
| Jun 30, 2019 |
17.08% |
| Mar 31, 2019 |
1.43% |
| Dec 31, 2018 |
-106.61% |
| Sep 30, 2018 |
1,260.86% |
| Jun 30, 2018 |
-49.72% |
| Mar 31, 2018 |
-17.72% |
| Dec 31, 2017 |
87.82% |
| Sep 30, 2017 |
91.62% |
| Jun 30, 2017 |
94.29% |
| Mar 31, 2017 |
-14.75% |
| Dec 31, 2016 |
11.57% |
| Sep 30, 2016 |
36.80% |
| Jun 30, 2016 |
-269.51% |
